Xspray Pharma
27.70 SEK
0.00 %
Less than 1K followers
XSPRAY
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xspray Pharma
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 77.82 | 181.45 | 59.95 | 53.31 | 37.75 | 39.59 | 30.58 |
| Shares | 16.7 | 18.4 | 22.1 | 24.2 | 33.1 | 38.9 | 42.9 |
| Market cap | 1,300.7 | 3,338.9 | 1,325.6 | 1,292.8 | 1,250.1 | 1,539.4 | 1,312.8 |
| Enterprise value | 1,096.2 | 3,018.2 | 1,056.9 | 1,174.7 | 1,120.6 | 1,459.4 | - |
| EV/S | - | - | - | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 3.48 | 5.73 | 2.24 | 2.33 | 1.80 | 2.47 | 2.17 |
| P/S | - | - | - | - | - | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 93.3 % | 96.2 % | 95.0 % | 95.0 % | 90.6 % | 78.2 % | 78.6 % |
| Gearing ratio | 1.4 % | 0.8 % | 0.5 % | 0.4 % | 5.3 % | 20.6 % | 24.5 % |